Compare Recursion Pharmaceuticals Inc (RXRX) vs Pacer Data & Infra Real Estate ETF (SRVR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Pacer Data & Infra Real Estate ETF — how do they compare? Recursion Pharmaceuticals Inc trades at $4.12 (market cap $2.14B), while Pacer Data & Infra Real Estate ETF trades at $28.88 (market cap $296.73M). The key difference: Recursion Pharmaceuticals Inc is far larger — about 7.2× Pacer Data & Infra Real Estate ETF's market cap, and Recursion Pharmaceuticals Inc is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 22 Days and Pacer Data & Infra Real Estate ETF for 10 Days on average.
| RXRX | SRVR | |
|---|---|---|
Market Cap | $2.14B | $296.73M |
Volume | 30,789,535 | 243,654 |
Sector | Health | Sector/Thematic |
52-Week High | $6.79 | $35.74 |
52-Week Low | $2.84 | $28.17 |
Typical Hold Time | 22 Days | 10 Days |
Enterprise Value | $1.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $4.05, down 5.15% today, with a bullish technical signal from moving averages. The company reported revenue of $74.26M in 2025 but a net loss of $644.76M, with negative profit margins. Recent news highlights strategic AI partnerships, including an extended data license with Tempus AI, aiming to fuel long-term growth despite current financial challenges.
The outlook remains speculative; the stock offers exposure to AI-driven drug discovery through a growing pipeline and partnerships, but high cash burn and lack of profitability pose significant risks. Analyst consensus is mixed with 40% buy ratings, reflecting optimism for future catalysts tempered by near-term financial weakness.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Pacer Data & Infra Real Estate ETF
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →
